Literature DB >> 7760193

Surgical treatment of jugular foramen schwannomas.

M Samii1, R P Babu, M Tatagiba, A Sepehrnia.   

Abstract

Sixteen patients with schwannomas of the jugular foramen were operated on in the Department of Neurosurgery of the Nordstadt Hospital in Hannover, Germany, between 1986 and 1992. Patients with neurofibromatosis were excluded. The records of the 16 patients were retrospectively reviewed. There were five women and 11 men (mean age 43 years) with a symptom duration ranging from 6 months to 20 years (mean 5 years). The predominant symptoms were hearing loss, hoarseness, and cerebellar symptoms. Computerized tomography (CT), magnetic resonance (MR) imaging, and angiography were performed in all 16 patients. Depending on the radiological and surgical features, the tumors were classified into four types: Type A, a tumor primarily at the cerebellopontine angle with minimal enlargement of the jugular foramen (eight cases); Type B, a tumor primarily at the jugular foramen with intracranial extension (two cases); Type C, a primarily extracranial tumor with extension into the jugular foramen (one case); and Type D, a dumbbell-shaped tumor with both intra- and extracranial components (five cases). A retromastoid suboccipital craniectomy was performed for Type A tumors, and a combined cervical-mastoidectomy for Types B, C, and D. Total tumor removal was achieved in all cases. There was no operative mortality. Postoperative complications were cerebrospinal fluid leakage in one patient and mastoiditis in two patients. The follow-up period ranged from 12 to 42 months (mean 22 months). All patients were alive at the last follow-up review, and CT and/or MR imaging showed no tumor recurrence.

Entities:  

Mesh:

Year:  1995        PMID: 7760193     DOI: 10.3171/jns.1995.82.6.0924

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  40 in total

1.  Posterior condylar canals and posterior condylar emissary veins-a microsurgical and CT anatomical study.

Authors:  Ken Matsushima; Masatou Kawashima; Toshio Matsushima; Tetsuya Hiraishi; Tomoyuki Noguchi; Akio Kuraoka
Journal:  Neurosurg Rev       Date:  2013-08-31       Impact factor: 3.042

2.  Glossopharyngeal nerve schwannoma: report of a case operated on by the far-lateral transcondylar approach.

Authors:  F Puzzilli; L Mastronardi; U Agrillo; P Nardi
Journal:  Skull Base Surg       Date:  1999

3.  Differential diagnosis of jugular foramen lesions.

Authors:  Thomas J Vogl; Sotirios Bisdas
Journal:  Skull Base       Date:  2009-01

4.  Nonvascular lesions of the jugular foramen: the gruppo otologico experience.

Authors:  Mario Sanna; Giuseppe De Donato; Filippo Di Lella; Maurizio Falcioni; Nitin Aggrawal; Guglielmo Romano
Journal:  Skull Base       Date:  2009-01

5.  Jugular foramen paragangliomas: management, outcome and avoidance of complications in a series of 75 cases.

Authors:  Orphée Makiese; Salvatore Chibbaro; M Marsella; P Tran Ba Huy; B George
Journal:  Neurosurg Rev       Date:  2011-09-23       Impact factor: 3.042

6.  Long-term outcomes after surgical treatment of jugular foramen schwannoma.

Authors:  Masafumi Fukuda; Makoto Oishi; Akihiko Saito; Yukihiko Fujii
Journal:  Skull Base       Date:  2009-11

7.  Imaging findings in schwannomas of the jugular foramen.

Authors:  O P Eldevik; T O Gabrielsen; E A Jacobsen
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

8.  Jugular foramen schwannomas: surgical approaches and outcome of treatment.

Authors:  H Yoo; H W Jung; H J Yang
Journal:  Skull Base Surg       Date:  1999

9.  Lower cranial nerves function after surgical treatment of Fisch Class C and D tympanojugular paragangliomas.

Authors:  Andrea Bacciu; Marimar Medina; Hassen Ait Mimoune; Flavia D'Orazio; Enrico Pasanisi; Giorgio Peretti; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-12       Impact factor: 2.503

10.  Dumbbell-shaped jugular foramen schwannomas: surgical management, outcome and complications on a series of 16 patients.

Authors:  S Chibbaro; G Mirone; O Makiese; D Bresson; B George
Journal:  Neurosurg Rev       Date:  2009-02-03       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.